The Hedgehog signaling pathway is one of the key regulators of animal development, and a signaling pathway which transmits information to embryonic cells required for proper cell differentiation. The name of pathway derives from its polypeptide ligand, an intercellular signaling molecule called Hedgehog (Hh) found in fruit flies of the genus Drosophila.
The evolutionarily conserved Hedgehog (Hh) pathway is essential for normal embryonic development and plays critical roles in adult tissue homeostasis, including maintenance, renewal and regeneration. Secreted Hh proteins act in a concentration- and time-dependent manner to initiate a series of cellular responses that range from survival and proliferation to cell fate specification and differentiation. Additionally, this pathway remains important during later stages of embryogenesis and metamorphosis.
As it shows in following figure, this pathway primary includes two parts.
In Hh's absence, the Ptch receptor localizes to the cilium, where it inhibits Smo activation. Gli proteins are phosphorylated by PKA, CKI and GSK3B and partially degraded into truncated Gli repressor form (GliR) that suppresses Hh target gene transcription in the nucleus.
In Hh's presence, Ptch disappears from the cilium, and activated Smo contributes to the translocation of the protein complex Gli, Sufu, Kif7 to ciliary tip, where Gli dissociates from the negative regulator Sufu. The production of Gli activator form (GliA) occurs and the increased nuclear accumulation of GliA results in activation transcription of Hh target genes.
In addition to critical roles in normal embryonic development and adult tissue homeostasis, aberrant Hh signaling pathway is responsible for the initiation of a growing number of cancers, including classically, basal cell carcinoma, rhabdomyosarcoma, and edulloblastoma.
Additionally, overactive Hh signaling has been implicated in pancreatic, lung, prostate, ovarian, and breast cancer. Thus, understanding the mechanisms that control Hh pathway activity will inform the development of novel therapeutics to treat a growing number of Hh-driven pathologies.
|GAS1||GAS1 Antibody||GAS1 Protein||GAS1 ELISA Kit|
|GLI1||GLI1 Antibody||GLI1 Protein||GLI1 ELISA Kit|
|GLI2||GLI2 Antibody||GLI2 Protein||GLI2 ELISA Kit|
|GLI3||GLI3 Antibody||GLI3 Protein||GLI3 ELISA Kit|
|GPR161||GPR161 Antibody||GPR161 Protein||GPR161 ELISA Kit|
|GRK2||GRK2 Antibody||GRK2 Protein||GRK2 ELISA Kit|
|GRK3||GRK3 Antibody||GRK3 Protein||GRK3 ELISA Kit|
|GSK3B||GSK3B Antibody||GSK3B Protein||GSK3B ELISA Kit|
|HHIP||HHIP Antibody||HHIP Protein||HHIP ELISA Kit|
|IHH||IHH Antibody||IHH Protein||IHH ELISA Kit|
|KIF3A||KIF3A Antibody||KIF3A Protein||KIF3A ELISA Kit|
|KIF7||KIF7 Antibody||KIF7 Protein||KIF7 ELISA Kit|
|LRP2||LRP2 Antibody||LRP2 Protein||LRP2 ELISA Kit|
|PRKACA||PRKACA Antibody||PRKACA Protein||PRKACA ELISA Kit|
|PRKACB||PRKACB Antibody||PRKACB Protein||PRKACB ELISA Kit|
|PRKACG||PRKACG Antibody||PRKACG Protein||PRKACG ELISA Kit|
|PTCH1||PTCH1 Antibody||PTCH1 Protein||PTCH1 ELISA Kit|
|PTCH2||PTCH2 Antibody||PTCH2 Protein||PTCH2 ELISA Kit|
|SHH||SHH Antibody||SHH Protein||SHH ELISA Kit|
|SMO||SMO Antibody||SMO Protein||SMO ELISA Kit|